Bone Marrow Transplant Market
PUBLISHED: 2023 ID: SMRC23979
SHARE
SHARE

Bone Marrow Transplant Market

Bone Marrow Transplant Market Forecasts to 2030 - Global Analysis By Transplant Type (Autologous Bone Marrow Transplant, Allogeneic Bone marrow Transplant and Other Transplant Types), Disease Indication (Leukemia, Lymphoma, Myeloma, Thalassemia, Myelodysplastic Syndrome, Myeloproliferative Disorders, Aplastic Anemia, Solid Tumors, Sickle cell Anemia and Other Disease Indications), End User and By Geography

4.6 (61 reviews)
4.6 (61 reviews)
Published: 2023 ID: SMRC23979

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Bone Marrow Transplant Market is accounted for $10.65 billion in 2023 and is expected to reach $15.39 billion by 2030 growing at a CAGR of 5.4% during the forecast period. In the interior of long bones, there is a soft vascular tissue called bone marrow. Hematopoietic and mesenchymal stem cells make up both types of stem cells. The main functions of bone marrow are hematopoiesis, lymphocyte production, and fat storage. Additionally, a unique form of treatment for people with certain cancers, such as leukemia, lymphoma, or other conditions, is bone marrow transplantation (BMT). Stem cells that are typically found in the bone marrow are removed during a bone marrow transplant, filtered, and then returned to the donor (patient) or to another individual.

According to data provided by the American Cancer Society, Inc., a voluntary health organization dedicated to eliminating cancer, in January 2022, Non-Hodgkin lymphoma (NHL) is one of the most common cancers in the U.S., accounting for about 4% of all cancers.

Market Dynamics:

Driver:

Increasing incidence of haematological disorders

Hematological disorders like leukemia, lymphoma, and multiple myeloma are becoming more commonplace in the world. Environmental exposures, alterations in lifestyle, and an aging population all play a role. Furthermore, as a result of improvements in diagnostics and early detection techniques, more cases are now being discovered at an earlier stage, which has raised interest in bone marrow transplantation as a potential treatment or cure. The number of patients who can benefit from transplantation has also increased as a result of the development of targeted therapies and precision medicine techniques, which can be combined with transplants to improve outcomes.

Restraint:

High transplantation costs

The high price of the procedure is one of the main barriers to the market for bone marrow transplants. The evaluation prior to the transplant, the conditioning regimens, the actual transplant, the post-transplant care, and long-term follow-up are all expensive procedures. Many patients may find these costs to be a barrier to care, even in areas with highly developed healthcare systems. Additionally, insurance might not always pay the full cost, leaving patients with sizable financial burdens.

Opportunity:

Modernization of personalized medicine

The field of bone marrow transplantation is greatly impacted by personalized medicine, which is driven by genomic and molecular profiling. Based on a person's genetic and molecular profile, it is possible to improve transplant outcomes and lower complications by customizing transplant strategies and post-transplant therapies. Moreover, this strategy reduces negative effects while improving the general efficacy of transplantation.

Threat:

Healthcare costs and economic constraints

The significant financial burden it places on patients and healthcare systems is one of the main threats to the bone marrow transplant market. Many patients may choose not to undergo transplantation due to the high costs involved, including those of pre-transplant evaluation, conditioning regimens, the actual transplantation, post-transplant care, and long-term follow-up. Additionally, high medical expenses can also put a strain on insurance plans and prevent underserved populations from receiving transplants.

Covid-19 Impact:

On the market for bone marrow transplants, the COVID-19 pandemic had a sizable effect. Worldwide healthcare systems were affected by the pandemic, which included the postponement or cancellation of non-urgent transplant procedures in order to conserve healthcare resources and reduce infection risks for susceptible patients. However, as concerns about transplant recipients Immuno-compromised states increased, strict infection control measures and modifications to transplant protocols became necessary.

The Leukemia segment is expected to be the largest during the forecast period

In the bone marrow transplant market, leukemia holds the largest market share. One of the most common and well-known causes of bone marrow transplantation is leukemia, which is characterized by the abnormal proliferation of white blood cells. The high prevalence of different leukemia types, such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML), significantly increases the demand for transplantation services. Moreover, the success rates for leukemia patients have also improved thanks to improvements in transplant methods, supportive care, and targeted therapies, which have further fueled this market's expansion.

The Ambulatory Surgical Centers segment is expected to have the highest CAGR during the forecast period

The bone marrow transplant market's, Ambulatory Surgical Centers (ASCs) segment holds the highest CAGR. ASCs provide a variety of outpatient surgical procedures, including some medical treatments and minimally invasive surgeries. Their growing popularity is a result of their capacity to offer affordable and practical healthcare, shorter hospital stays, and lower infection risks. Additionally, ASCs have diversified their offerings in recent years to include a number of specialties, such as orthopedics, ophthalmology, gastroenterology, and pain management.

Region with largest share:

The North American region holds the largest market share for bone marrow transplants. This dominance can be attributed to a number of things, including a strong regulatory environment, an established healthcare infrastructure, a high prevalence of haematological disorders requiring bone marrow transplants, and cutting-edge medical technologies. Additionally, North America benefits from extensive research and development efforts, significant healthcare expenditures, and a sizable donor pool. The region's market leadership has also been aided by growing patient and healthcare provider awareness of the advantages of bone marrow transplantation.

Region with highest CAGR:

The market for bone marrow transplants has seen the highest CAGR in the Middle East and North Africa (MENA) region. Increased healthcare investments, a growing healthcare infrastructure, and rising public awareness of cutting-edge treatments like bone marrow transplants are a few of the factors driving this growth. Moreover, the United Arab Emirates, Saudi Arabia, and Qatar are among the MENA nations that have made significant improvements to their healthcare infrastructure, enabling their populations to access bone marrow transplantation more easily. The rising demand for transplantation services is also a result of the region's increasing prevalence of haematological disorders, which is fueling the market's expansion.

Key players in the market

Some of the key players in Bone Marrow Transplant market include Gamida Cell Ltd., Mesoblast Ltd., American Type Culture Collection (ATCC) Inc, Lonza Group Ltd., FUJIFILM Cellular Dynamics, Inc., ReachBio LLC., Sanofi-Aventis LLC., PromoCell GmbH, Abbott Laboratories Inc, The Emmes Company LLC, CORESTEM, Inc., StemCell Technologies., Hemacare Corporation, AllCells LLC., Lifeline Cell Technology LLC, ReeLabs Pvt. Ltd., Charles River Laboratories and Merck Millipore Corporation .

Key Developments:

In June 2023, Lonza, a trusted partner of the pharmaceutical, biotech, and nutrition industries, has entered into a ten-year Virtual Power Purchase Agreement with IGNIS. A VPPA represents a tailored and adaptable solution that caters to the needs of companies like Lonza, which operates in multiple sites. Unlike traditional power purchase agreements, VPPAs offer more flexibility and attract investments in the solar electricity production facilities as they are not linked to photovoltaic production facilities through physical grids.

In January 2023, FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cells (iPSC), announced today that it has entered an agreement to grant global healthcare company Novo Nordisk A/S a non-exclusive right to use FUJIFILM Cellular Dynamics’ iPSC platform for the development and commercialization of iPSC-derived cell therapies with a focus on addressing serious chronic diseases.

In October 2020, Gamida Cell Ltd., a leading cellular and immune therapeutics company, and Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies, today announced an expansion of their existing strategic collaboration for omidubicel, Gamida Cell’s advanced cell therapy in Phase 3 clinical development as a potentially life-saving treatment option for patients in need of an allogeneic hematopoietic stem cell transplant.

Transplant Types Covered:
• Autologous Bone Marrow Transplant
• Allogeneic Bone marrow Transplant
• Other Transplant Types

Disease Indications Covered:
• Leukemia
• Lymphoma
• Myeloma
• Thalassemia
• Myelodysplastic Syndrome
• Myeloproliferative Disorders
• Aplastic Anemia
• Solid Tumors
• Sickle cell Anemia
• Other Disease Indications

End Users Covered:
• Hospitals
• Multispecialty Clinics
• Ambulatory Surgical Centers
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Bone Marrow Transplant Market, By Transplant Type
5.1 Introduction
5.2 Autologous Bone Marrow Transplant
5.3 Allogeneic Bone marrow Transplant
5.4 Other Transplant Types

6 Global Bone Marrow Transplant Market, By Disease Indication
6.1 Introduction
6.2 Leukemia
6.3 Lymphoma
6.4 Myeloma
6.5 Thalassemia
6.6 Myelodysplastic Syndrome
6.7 Myeloproliferative Disorders
6.8 Aplastic Anemia
6.9 Solid Tumors
6.10 Sickle cell Anemia
6.11 Other Disease Indications

7 Global Bone Marrow Transplant Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Multispecialty Clinics
7.4 Ambulatory Surgical Centers
7.5 Other End Users

8 Global Bone Marrow Transplant Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Gamida Cell Ltd.
10.2 Mesoblast Ltd.
10.3 American Type Culture Collection (ATCC) Inc
10.4 Lonza Group Ltd.
10.5 FUJIFILM Cellular Dynamics, Inc.
10.6 ReachBio LLC.
10.7 Sanofi-Aventis LLC.
10.8 PromoCell GmbH
10.9 Abbott Laboratories Inc
10.10 The Emmes Company LLC
10.11 CORESTEM, Inc.
10.12 StemCell Technologies.
10.13 Hemacare Corporation
10.14 AllCells LLC.
10.15 Lifeline Cell Technology LLC
10.16 ReeLabs Pvt. Ltd.
10.17 Charles River Laboratories
10.18 Merck Millipore Corporation

List of Tables
1 Global Bone Marrow Transplant Market Outlook, By Region (2021-2030) ($MN)
2 Global Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
3 Global Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
4 Global Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
5 Global Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
6 Global Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
7 Global Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
8 Global Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
9 Global Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
10 Global Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
11 Global Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
12 Global Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
13 Global Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
14 Global Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
15 Global Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
16 Global Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
17 Global Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
18 Global Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
19 Global Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
20 Global Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
21 Global Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
22 North America Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
23 North America Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
24 North America Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
25 North America Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
26 North America Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
27 North America Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
28 North America Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
29 North America Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
30 North America Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
31 North America Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
32 North America Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
33 North America Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
34 North America Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
35 North America Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
36 North America Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
37 North America Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
38 North America Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
39 North America Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
40 North America Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
41 North America Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
42 North America Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
43 Europe Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
44 Europe Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
45 Europe Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
46 Europe Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
47 Europe Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
48 Europe Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
49 Europe Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
50 Europe Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
51 Europe Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
52 Europe Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
53 Europe Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
54 Europe Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
55 Europe Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
56 Europe Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
57 Europe Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
58 Europe Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
59 Europe Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
60 Europe Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
61 Europe Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
62 Europe Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
63 Europe Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
64 Asia Pacific Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
65 Asia Pacific Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
66 Asia Pacific Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
67 Asia Pacific Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
68 Asia Pacific Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
69 Asia Pacific Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
70 Asia Pacific Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
71 Asia Pacific Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
72 Asia Pacific Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
73 Asia Pacific Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
74 Asia Pacific Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
75 Asia Pacific Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
76 Asia Pacific Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
77 Asia Pacific Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
78 Asia Pacific Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
79 Asia Pacific Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
80 Asia Pacific Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
81 Asia Pacific Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
82 Asia Pacific Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
83 Asia Pacific Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
84 Asia Pacific Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
85 South America Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
86 South America Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
87 South America Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
88 South America Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
89 South America Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
90 South America Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
91 South America Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
92 South America Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
93 South America Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
94 South America Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
95 South America Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
96 South America Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
97 South America Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
98 South America Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
99 South America Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
100 South America Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
101 South America Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
102 South America Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
103 South America Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
104 South America Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
105 South America Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
106 Middle East & Africa Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
107 Middle East & Africa Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
108 Middle East & Africa Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
109 Middle East & Africa Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
110 Middle East & Africa Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
111 Middle East & Africa Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
112 Middle East & Africa Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
113 Middle East & Africa Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
114 Middle East & Africa Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
115 Middle East & Africa Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
116 Middle East & Africa Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
117 Middle East & Africa Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
118 Middle East & Africa Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
119 Middle East & Africa Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
120 Middle East & Africa Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
121 Middle East & Africa Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
122 Middle East & Africa Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
123 Middle East & Africa Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
124 Middle East & Africa Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
125 Middle East & Africa Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
126 Middle East & Africa Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)

List of Figures

List of Figures
Figure 1 Global Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 2 North America Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 3 US Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 4 Canada Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 6 Europe Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 7 Germany Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 8 UK Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 9 Italy Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 10 France Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 11 Spain Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 14 Japan Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 15 China Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 16 India Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 17 Australia Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 21 South America Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 24 Chile Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 28 UAE Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Bone Marrow Transplant Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Bone Marrow Transplant Market Outlook (2021-2030) ($MN)

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials